中国脓毒症/脓毒性休克急诊治疗指南(2018)

[31] Arginine vasopressin in advanced vasodilatory shock -: A prospective, randomized, controlled study [J]. CIRCULATION, 2003, 107 (18) : 2313 - 2319

[32] Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial [J]. CRITICAL CARE MEDICINE, 2002, 30 (10) : 2205 - 2211

[33] Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units:: results from a multicenter prospective epidemiological survey [J]. INTENSIVE CARE MEDICINE, 2002, 28 (10) : 1411 - 1418

[34] A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10;000/L versus 20;000/microL trigger.[J].Marc S Zumberg;Maria Luz U del Rosario;Christine F Nejame;Brad H Pollock;Linda Garzarella;K.J Kao;Richard Lottenberg;John R Wingard.Biology of Blood and Marrow Transplantation.2002, 10

[35] Terlipressin for norepinephrine-resistant septic shock [J]. LANCET, 2002, 359 (9313): : 1209 - 1210

[36] Acute renal failure in the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (05) : 875 - 885

[37] Beneficial effects of short-term vasopressin infusion during severe septic shock [J]. ANESTHESIOLOGY, 2002, 96 (03) : 576 - 582

[38] Continuous versus intermittent renal replacement therapy: a meta-analysis [J]. INTENSIVE CARE MEDICINE, 2002, 28 (01) : 29 - 37

[39] The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series [J]. INTENSIVE CARE MEDICINE, 2001, 27 (08) : 1416 - 1421

[40] Source control in the management of sepsis.[J].Maria F. Jimenez;J. C. Marshall.Intensive Care Medicine.2001, 1

[31] Arginine vasopressin in advanced vasodilatory shock -: A prospective, randomized, controlled study [J]. CIRCULATION, 2003, 107 (18) : 2313 - 2319

[32] Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial [J]. CRITICAL CARE MEDICINE, 2002, 30 (10) : 2205 - 2211

[33] Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units:: results from a multicenter prospective epidemiological survey [J]. INTENSIVE CARE MEDICINE, 2002, 28 (10) : 1411 - 1418

[34] A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10;000/L versus 20;000/microL trigger.[J].Marc S Zumberg;Maria Luz U del Rosario;Christine F Nejame;Brad H Pollock;Linda Garzarella;K.J Kao;Richard Lottenberg;John R Wingard.Biology of Blood and Marrow Transplantation.2002, 10

[35] Terlipressin for norepinephrine-resistant septic shock [J]. LANCET, 2002, 359 (9313): : 1209 - 1210

[36] Acute renal failure in the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (05) : 875 - 885

[37] Beneficial effects of short-term vasopressin infusion during severe septic shock [J]. ANESTHESIOLOGY, 2002, 96 (03) : 576 - 582

[38] Continuous versus intermittent renal replacement therapy: a meta-analysis [J]. INTENSIVE CARE MEDICINE, 2002, 28 (01) : 29 - 37

[39] The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series [J]. INTENSIVE CARE MEDICINE, 2001, 27 (08) : 1416 - 1421

[40] Source control in the management of sepsis.[J].Maria F. Jimenez;J. C. Marshall.Intensive Care Medicine.2001, 1